Back to trial details

Intake questionnaire

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

Applying to Houston Methodist Cancer Center · Houston, Texas

Answer a few short questions to share with the research team.

0 of 4 answered

1. Are you 18 years old or older?
2. Have you been diagnosed with Breast Cancer, Metastatic?
3. Are you currently pregnant or breastfeeding?
4. Are you able to travel to Houston for study visits?